{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:29:58Z","timestamp":1761560998442},"reference-count":33,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2005,9,23]],"date-time":"2005-09-23T00:00:00Z","timestamp":1127433600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2005,10]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Background<\/jats:bold> :\u2002Barrett's oesophagus patients may continue to have abnormal oesophageal acid exposure on proton pump inhibitor therapy. The effect of factors such as Barrett's oesophagus length, hiatal hernia size and <jats:italic>Helicobacter pylori<\/jats:italic> infection on intra\u2010oesophageal pH in Barrett's oesophagus patients has not been adequately studied.<\/jats:p><jats:p><jats:bold>Aim<\/jats:bold> :\u2002To evaluate oesophageal acid exposure in a large Barrett's oesophagus population on b.d. proton pump inhibitor therapy and determine clinical factors predicting normalization of intra\u2010oesophageal pH on therapy.<\/jats:p><jats:p><jats:bold>Methods<\/jats:bold> :\u2002Barrett's oesophagus patients were studied using 24\u2003h pH monitoring to evaluate intra\u2010oesophageal acid suppression on b.d. dosing of rabeprazole.<\/jats:p><jats:p><jats:bold>Results<\/jats:bold> :\u2002Forty\u2010six Barrett's oesophagus patients completed the study. Median total percentage time pH\u2003&lt;\u20034 was 1.05% (range: 0\u201329.9%) in the entire group and respective values for upright and supine percentage time pH\u2003&lt;\u20034 were 1.15% and 0%. However, 34 of the Barrett's oesophagus patients (73.9%) had a normal pH study (median total percentage time pH\u2003&lt;\u20034: 0.2%) and 12 patients (26.1%) had an abnormal result (median total percentage time pH\u2003&lt;\u20034: 9.3%). There were no significant differences between patients with a normal and abnormal 24\u2003h pH result with respect to age, Barrett's oesophagus length, hiatal hernia size and presence of <jats:italic>H. pylori<\/jats:italic> infection.<\/jats:p><jats:p><jats:bold>Conclusions<\/jats:bold> :\u2002Approximately 25% of Barrett's oesophagus patients continue to have abnormal total intra\u2010oesophageal pH profiles despite b.d. proton pump inhibitor therapy. Factors such as age, Barrett's oesophagus length and hiatal hernia size cannot be used to predict persistent abnormal intra\u2010oesophageal pH on proton pump inhibitor.<\/jats:p>","DOI":"10.1111\/j.1365-2036.2005.02626.x","type":"journal-article","created":{"date-parts":[[2005,9,23]],"date-time":"2005-09-23T09:31:27Z","timestamp":1127467887000},"page":"627-633","source":"Crossref","is-referenced-by-count":21,"title":["Lack of predictors of normalization of oesophageal acid exposure in Barrett's oesophagus"],"prefix":"10.1111","volume":"22","author":[{"given":"S.","family":"WANI","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. E.","family":"SAMPLINER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. P.","family":"WESTON","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"MATHUR","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"HALL","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"HIGBEE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"SHARMA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,9,23]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1111\/j.1572-0241.2002.05910.x","article-title":"Practice parameters committee of the ACG. Updated guidelines for the diagnosis, surveillance and therapy of Barrett's esophagus","volume":"97","author":"Sampliner RE","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1159\/000016850"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0046-8177(94)90057-4"},{"key":"e_1_2_6_5_2","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0889-8553(21)00590-2","article-title":"Barrett's esophagus and esophageal adenocarcinoma","volume":"20","author":"Reid BJ","year":"1991","journal-title":"Gastroenterol Clin N Am"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9610(05)81193-6"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5223(19)33854-1"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.1983.01390050027005"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.31.9.964"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2002.05770.x"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2004.02127.x"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-199705000-00019"},{"key":"e_1_2_6_13_2","first-page":"989","article-title":"Successful elimination of reflux symptoms does not ensure adequate control of acid reflux in Barrett's esophagus","volume":"89","author":"Katzka DA","year":"1994","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_14_2","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/j.1572-0241.1998.211_a.x","article-title":"Complete elimination of reflux symptoms does not guarantee normalization of intra\u2010esophageal acid reflux in patients with Barrett's esophagus","volume":"93","author":"Ouata\u2010Lascar R","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2000.00749.x"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1442-2050.2003.00327.x"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5107(96)70055-X"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1990.tb00495.x"},{"key":"e_1_2_6_19_2","first-page":"582","article-title":"Normalization of esophageal pH with high dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus","volume":"92","author":"Sharma P","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200211000-00005"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2168.1996.02129.x"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.139.5.547"},{"key":"e_1_2_6_23_2","first-page":"1527","article-title":"Persistent acid secretion during omeprazole therapy: a study of gastric acid profiles in patients demonstrating failure of omeprazole therapy","volume":"91","author":"Leite LP","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00641.x"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.48.3.310"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119018"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1999.0029900327"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1993.tb00143.x"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.45.4.489"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1998.00389.x"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00593.x"},{"key":"e_1_2_6_32_2","first-page":"260","article-title":"Effect of maximal acid reflux control on Barrett's esophagus","volume":"94","author":"Srinivasan R","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.04.010"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2004.30228.x"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2005.02626.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2005.02626.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T21:37:55Z","timestamp":1697233075000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2005.02626.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9,23]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["10.1111\/j.1365-2036.2005.02626.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2005.02626.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,9,23]]}}}